Net Income Common - RaQualia Pharma Inc (TSE:4579) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 601 JPY -1.31%

Updated:

RaQualia Pharma Inc
Net Income (Common)

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

RaQualia Pharma Inc
Net Income (Common) Peer Comparison

4502

4568

4578

4519

4503

Company		Net Income (Common)	CAGR 3Y	CAGR 5Y	CAGR 10Y
	RaQualia Pharma Inc TSE:4579	Net Income (Common) -¥323.7m	CAGR 3-Years 19%	CAGR 5-Years 22%	CAGR 10-Years 12%
	Takeda Pharmaceutical Co Ltd TSE:4502	Net Income (Common) ¥178.2B	CAGR 3-Years 0%	CAGR 5-Years 10%	CAGR 10-Years 2%
	Daiichi Sankyo Co Ltd TSE:4568	Net Income (Common) ¥186.1B	CAGR 3-Years 38%	CAGR 5-Years 23%	CAGR 10-Years 5%
	Otsuka Holdings Co Ltd TSE:4578	Net Income (Common) ¥121.6B	CAGR 3-Years -6%	CAGR 5-Years 8%	CAGR 10-Years -4%
	Chugai Pharmaceutical Co Ltd TSE:4519	Net Income (Common) ¥325.5B	CAGR 3-Years 15%	CAGR 5-Years 29%	CAGR 10-Years 20%
	Astellas Pharma Inc TSE:4503	Net Income (Common) ¥37.3B	CAGR 3-Years -35%	CAGR 5-Years -29%	CAGR 10-Years -9%

See Also

Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Net Income (Common) amounts to -323.7m JPY.

The average annual Net Income (Common) growth rates for RaQualia Pharma Inc have been 19% over the past three years , 22% over the past five years , and 12% over the past ten years .

Join more than 135,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.